Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    AstraZeneca Pharma Gets CDSCO Nod To Sell Enhertu For Breast Cancer

    15 hours ago

    AstraZeneca Pharma India received approval from the CDSCO to import and sell Enhertu for an additional HER2 positive breast cancer indication in India.
    Click here to Read More
    Previous Article
    Assam Floods: Situation Remains Critical As Death Toll Climbs To 98
    Next Article
    Jana Nayagan Box Office Collection Day 16: Vijay's Film Crosses Rs 310 Cr Worldwide

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment